FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

DXCM

DexcomNASDAQ · Health Care Equipment · Health Care
Previous close
87.34
Change
+0.89 / +1.03%
FinDog View
Bullish
52-Week Range
54.11 – 92.59
P/E (TTM)
31.8
Forward P/E
26.1
Based on consensus earnings for the next 12 months
Market Cap
$33.0B
1M
−1.60%
S&P 500 −2.41% over same period
Volume / Avg Volume
3.6M / 3.7M
0.99× average

Price History

Closing price · USD1M6M1Y5Y
82.58587.59092.52026-082026-082026-092026-092026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 35.01M6M1Y5Y
20304050602025-092025-122026-032026-062026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-30$1.3B0.70 / 0.62+11.95%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-30$1.2B0.56 / 0.48+3.02%Pending
FY2025 Q4
Quarter ended 2025-12
2026-01-12—— / —−1.03%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-30$1.2B0.61 / 0.58−14.63%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-30$1.2B0.48 / —−9.31%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-01$1.0B0.27 / —+16.17%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 10 of its 5-year rangeCheap
5-year range 30.2 – 131.3 · Median 49.5
Last 4 quarters: $500M in buybacks + $0 in dividends, 1.52% of market cap combined
P/E (TTM)
31.8
P/B
12.1
P/S
6.4
PEG
1.14
Earnings Reaction
Over the last 6 reports, the stock moved ±9.4% on average on the first trading day after, rising 3 times
Most recent +11.95%
Volatility & Correlation
1-year beta 0.65 · Correlation with S&P 500 0.20Low beta
Annualized volatility 41% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 13 · $8.4MNet selling $8.4M
  • 09-15Brown Michael JonEVP Chief Legal Compliance OffSell$0.14M1,700 shares · Avg price 84.04
  • 09-15AUGUSTINOS NICHOLASDirectorSell$0.55M6,539 shares · Avg price 84.04
  • 09-14AUGUSTINOS NICHOLASDirectorSell$0.13M1,550 shares · Avg price 84.02
  • 09-10Sylvain Jereme MEVP, Chief Financal OfficerSell$0.30M3,638 shares · Avg price 83.27
  • 08-27Stern SadieEVP Chief People & Culture OffSell$0.23M2,565 shares · Avg price 88.37
  • 08-20SAYER KEVIN RExecutive ChairSell$2.4M26,756 shares · 3 trades · Avg price 90.01
  • 08-14Brown Michael JonEVP Chief Legal Compliance OffSell$0.16M1,700 shares · Avg price 91.93
  • 08-12Heller Bridgette PDirectorSell$0.09M1,012 shares · Avg price 88.29
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q21.31+13.1%63.4%0.320.250.180.64
FY2026 Q11.19+15.0%62.9%0.260.200.450.51
FY2025 Q41.26+13.1%62.9%0.320.270.190.67
FY2025 Q31.21+21.6%60.5%0.240.280.580.70
FY2025 Q21.16+15.2%59.5%0.210.180.210.45
FY2025 Q11.04+12.5%56.9%0.130.110.100.27
FY2024 Q41.11+7.6%58.9%0.190.150.180.37
FY2024 Q30.99+2.0%59.7%0.150.130.090.34
FY2024 Q21.00+15.3%62.4%0.160.140.210.35
FY2024 Q10.92+24.2%61.0%0.100.150.150.36
FY2023 Q41.03+26.9%63.5%0.220.260.080.61
FY2023 Q30.98+26.7%63.9%0.210.120.220.29

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
DXCMDexcom$33.0B31.8+13.1%63.4%−1.60%Bullish
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare